Cargando…
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of global concern. Other than the profound severe pulmonary damage, SARS-CoV-2 infection also leads to a series of cardiovascular abnorma...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306106/ https://www.ncbi.nlm.nih.gov/pubmed/32579957 http://dx.doi.org/10.1016/j.bcp.2020.114114 |